Skip to content

Clinical trials

Phase 3 Hemorrhage trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 3 Country / region: Austria Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20072
20092
20111
20141
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Idorsia Pharmaceuticals Ltd.2
Assistance Publique - Hôpitaux de Paris1
AstraZeneca1
Bayer1
Boehringer Ingelheim1
Medical University of Vienna1
Pfizer1
SFJ Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage9
Subarachnoid Hemorrhage2
Cataplexy1
Critical Illness1
Hemophilia A1
Hemophilia B1
Ischemia1
Ischemic Attack, Transient1
Pulmonary Embolism1
Stroke1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.